Article Information
History
- May 1, 2023.
Article Versions
- Version 1 (January 5, 2022 - 23:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mineto Ota1,2,*,
- Masahiro Nakano1,3,
- Yasuo Nagafuchi1,2,
- Satomi Kobayashi1,
- Hiroaki Hatano1,4,
- Ryochi Yoshida1,
- Yuko Akutsu1,
- Takahiro Itamiya1,
- Nobuhiro Ban5,
- Yumi Tsuchida1,
- Hirofumi Shoda1,
- Kazuhiko Yamamoto1,3,
- Kazuyoshi Ishigaki4,
- Tomohisa Okamura2 and
- Keishi Fujio1,*
- 1Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo; Bunkyo-ku, Tokyo, 113-0033, Japan
- 2Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo; Bunkyo-ku, Tokyo, 113-0033, Japan
- 3Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences; Yokohama, Kanagawa, 230-0045, Japan
- 4Laboratory for Human Immunogenetics, RIKEN Center for Integrative Medical Sciences; Yokohama, Kanagawa, 230-0045, Japan
- 5Research Division, Chugai Pharmaceutical Co., Ltd.; Yokohama, Kanagawa, 244-0003, Japan
- ↵*Correspondence: mineto{at}stanford.edu (M.O.), fujiok-int{at}h.u-tokyo.ac.jp (K.F.)
Posted May 01, 2023.
Multimodal repertoire analysis unveils B cell biology in immune-mediated diseases
